Dr. Nishitha M. Reddy, MD

Dr. Reddy practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Reddy's NPI, 1710177654, was assigned on July 26, 2007. Dr. Reddy holds Tennessee license 42381.

Dr. Reddy's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Reddy's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Reddy is also affiliated with North Alabama Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Reddy to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Reddy is licensed in Tennessee.

CMS data shows 93 Medicare services from Dr. Reddy across 1 procedure code in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $6,436 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Reddy in 2024. The largest group is 75 to 84, with 21 patients. 68% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 75, with 47% women.

In 2024, Dr. Reddy wrote 151 Medicare Part D claims for 26 patients. 60% of them were for generic drugs. CMS names the drug for 112 of them, across 4 drugs with 11 or more claims each, at $698,605 in total drug cost. In 2023, CMS named 76 claims across 3 drugs.

Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth.

Dmand AI links 43 papers to Dr. Reddy, published from 2017 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents, Immunological and Hematopoietic Stem Cell Transplantation. Dr. Reddy has published most often in Blood Adv. Dr. Reddy's most frequent co-authors are Reem Md Karmali, MD, Paolo F. Caimi, MD and Veronika Bachanova, MD.

CMS Open Payments shows 204 general payments to Dr. Reddy from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Gilead Sciences, Inc. paid the most, $50,410. It also lists 1 research payment totaling $330 in 2021.